Elevance Health Enhances Healthcare Services, Reaching Over 109 Million Consumers
Written by Emily J. Thompson, Senior Investment Analyst
Source: Newsfilter
Updated: 9 hour ago0mins
- Comprehensive Health Support: Elevance Health enhances support for members facing cancer diagnoses, mental health crises, and unexpected pregnancy health issues through partnerships with care providers, significantly improving health outcomes and member confidence in navigating complex healthcare situations.
- Personalized Care Innovation: The company's Medicare Advantage and Medicaid plans provide funding for nutritious food, over-the-counter medications, and transportation services, which contribute to improved health outcomes and reflect Elevance's commitment to addressing individual health needs.
- Community Partnership Expansion: Elevance Health invests in community relationships, leveraging data to understand health determinants, and implements initiatives like on-site food pantries in schools, thereby enhancing overall community health and strengthening local influence.
- Data-Driven Care Coordination: The Community Pharmacy Total Care program collaborates with independent pharmacies to offer personalized solutions for members with complex health conditions, improving management of diabetes and chronic diseases, which enhances service quality and member satisfaction.
ELV.N
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on ELV
Wall Street analysts forecast ELV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELV is 392.07 USD with a low forecast of 343.00 USD and a high forecast of 425.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
11 Buy
3 Hold
0 Sell
Strong Buy
Current: 360.220
Low
343.00
Averages
392.07
High
425.00
Current: 360.220
Low
343.00
Averages
392.07
High
425.00
TD Cowen
Buy
upgrade
$380 -> $400
2025-11-26
Reason
TD Cowen
Price Target
$380 -> $400
2025-11-26
upgrade
Buy
Reason
TD Cowen raised the firm's price target on Elevance Health to $400 from $380 and keeps a Buy rating on the shares. The firm said it is a Best Idea for 2026. Managed care continues to be a complicated investment landscape, but we see the company's current 2026 EPS consensus as appropriate and a basis for growth.
Mizuho
Outperform
to
NULL
downgrade
$420 -> $400
2025-11-03
Reason
Mizuho
Price Target
$420 -> $400
2025-11-03
downgrade
Outperform
to
NULL
Reason
Mizuho lowered the firm's price target on Elevance Health to $400 from $420 and keeps an Outperform rating on the shares. The firm reduced 2026 and 2027 earnings estimates to reflect additional headwinds in Carelon related to the expected regulatory driven membership changes. The firm assumes Elevance faces membership pressure in its Medicaid, Medicare Advantage and the health insurance exchange businesses due to the potential expiration of the enhanced advanced premium tax credits.
JPMorgan
NULL -> Overweight
upgrade
$384 -> $394
2025-10-28
Reason
JPMorgan
Price Target
$384 -> $394
2025-10-28
upgrade
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Elevance Health to $394 from $384 and keeps an Overweight rating on the shares. The firm updated the company's model post the earnings report.
TD Cowen
Buy
maintain
$330 -> $380
2025-10-23
Reason
TD Cowen
Price Target
$330 -> $380
2025-10-23
maintain
Buy
Reason
TD Cowen raised the firm's price target on Elevance Health to $380 from $330 and keeps a Buy rating on the shares. The firm noted the company maintained FY25 guide but FY26 implied lower versus consensus on a more negative MDCD outlook, offset by more upbeat MA expectations.
See All Ratings
About ELV
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
What does Elevance Health's surpassing of the 200-day moving average indicate?
How does the Virtual Assistant improve Elevance Health members' healthcare experience?
Will Elevance Health's stock price continue to rise after surpassing the moving average?
How might the Virtual Assistant's expansion to Medicare members impact Elevance's growth?